Dr. Luis E. Fayad, MD
- Medicare services, 2024
- 894
- Medicare patients, 2024
- 280
- Part D claims, 2024
- 350
- Publications
- 219
- Clinical trials
- 5
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Fayad's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Luis E. Fayad is a hematologist and oncologist in Houston, Texas
Dr. Fayad practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Fayad's NPI, 1205921095, was assigned on October 4, 2006. Dr. Fayad graduated from Universidad Catolica de Santiago de Guayaquil in 1985. Dr. Fayad holds Texas license J7482.
- NPI
- 1205921095NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4981897006
- NPI enumeration date
- October 4, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 67
- Medical school graduation
- 1985
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Luis E. Fayad practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Fayad's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Luis E. Fayad is affiliated with 1 site of care and 1 medical group
Dr. Fayad's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Luis E. Fayad's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fayad practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Luis E. Fayad is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Fayad's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Fayad's licenses on file in 5 states: Texas, Florida, Oklahoma, Arizona and Nevada.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- Florida license
- Oklahoma license
- Arizona license
- Nevada license
Clinical focus
Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lymphoma and multiple myeloma among the conditions Dr. Fayad treats.
Hematologists and oncologists near Dr. Fayad
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Luis E. Fayad billed Medicare for 894 services in 2024
CMS data shows 894 Medicare services from Dr. Fayad across 9 procedure codes in 2024, for 280 Medicare patients. Medicare paid $74,907 for them.
Dr. Fayad's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8922024: 894No change
Where Dr. Fayad's Medicare services took place, 2024
- In an office556%
- In a facility83994%
Dr. Fayad compared with the Texas median for hematologists and oncologists, 2024
- Dr. Fayad
- Texas median
- Medicare services
- 894vs 1,16223% below
- Medicare patients
- 280vs 25112% above
- Part D claims
- 179vs 48963% below
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Fayad's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Fayad?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Fayad and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Luis E. Fayad treated 280 Medicare patients in 2024, average age 72
CMS counts 280 Medicare patients who saw Dr. Fayad in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Fayad's median patient age at 72, with 40% women.
Dr. Fayad's Medicare patients by age, 2024
Dr. Fayad's Medicare patients by sex, 2024
- Women10939%
- Men17161%
Chronic conditions among Dr. Fayad's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis52%
- Diabetes37%
- Ischemic heart disease36%
- Anxiety34%
- Chronic kidney disease33%
- Mood disorders31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Fayad's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women40%
- Men60%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Luis E. Fayad wrote 350 Medicare Part D claims in 2024
In 2024, Dr. Fayad wrote 350 Medicare Part D claims for 96 patients. 86% of them were for generic drugs. CMS names the drug for 179 of them, across 8 drugs with 11 or more claims each, at $432,280 in total drug cost. In 2023, CMS named 127 claims across 6 drugs.
Dr. Fayad's Part D claims by kind of drug, 2024
- Generic300 claims86%
- Brand-name and other50 claims14%
Dr. Fayad's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Fayad's Part D claims, 2024
- Antibiotics14%48 of 350 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1272024: 17941%
Drugs named by CMS: 8 in 2024, 6 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Luis E. Fayad scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Fayad for performance year 2024, reported as part of a group. Dr. Fayad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fayad as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Fayad's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Luis E. Fayad has 219 publications on record
Dmand AI links 219 papers to Dr. Fayad, published from 2004 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Rituximab and Lymphoma, Large B-Cell, Diffuse. Dr. Fayad has published most often in Leuk Lymphoma. Dr. Fayad's most frequent co-authors are Sattva S. Neelapu, MD, Fredrick B. Hagemeister, MD and Jason R. Westin, MD.
Dr. Fayad's papers by year, 2016 to 2025
Topics Dr. Fayad writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Rituximab
- Lymphoma, Large B-Cell, Diffuse
- Doxorubicin
- Cyclophosphamide
- Vincristine
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents
Dr. Fayad's most frequent co-authors
- Sattva S. Neelapu, MD84 shared papers
- Fredrick B. Hagemeister, MD72 shared papers
- Jason R. Westin, MD70 shared papers
Recent publications by Dr. Fayad
See who Dr. Fayad researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Fayad works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Luis E. Fayad has worked on 5 clinical trials
Dmand AI links Dr. Fayad to 5 clinical trials, 4 of them phase 2 studies. Conditions studied include Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse and Lymphoma, Non-Hodgkin. M.D. Anderson Cancer Center sponsors the most, 2.
Clinical trials with Dr. Fayad by phase
- 1Phase 1: 1 trial
- 4Phase 2: 4 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Fayad's trials
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Mantle-Cell
Investigators on the most trials with Dr. Fayad
- Ranjana Advani, MD1 shared trial
- Stephen M. Ansell, MD1 shared trial
- Nancy Lee Bartlett, MD1 shared trial
Recent clinical trials with Dr. Fayad
FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (opens in a new tab)
Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy (opens in a new tab)
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Luis E. Fayad received $22,047 in industry payments from 2016 to 2025
CMS Open Payments shows 50 general payments to Dr. Fayad from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 28% of the total. Amgen Inc. paid the most, $12,848. It also lists 2 research payments totaling $1,233 in 2024.
General payments to Dr. Fayad by program year, 2016 to 2025
General payments to Dr. Fayad by kind, 2016 to 2025
- Speaker and faculty fees$6,16028%
- Consulting fees$5,61325%
- Food and beverage$4,63621%
- Honoraria$3,00014%
- Other$2,63812%
Companies that paid Dr. Fayad the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Luis E. Fayad has 1 award and honors on record
Dmand AI lists 1 award for Dr. Fayad, most recently Regional Top Doctor in 2014.
Awards and honors for Dr. Fayad
- 2014
- Regional Top Doctor
Source: Dmand AI Professional Profile Data
Dr. Luis E. Fayad graduated from Universidad Catolica de Santiago de Guayaquil
Dr. Fayad graduated from Universidad Catolica de Santiago de Guayaquil in 1985.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Luis E. Fayad accepts plans from 14 insurance carriers
Dr. Fayad is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Alliant Health Plans
- Elevance
- HCSC
- Baylor Scott and White
- Blue Cross and Blue Shield of Kansas City
- +6 more carriersWith a free account
Plan types Dr. Fayad accepts, by number of carriers
- HMO9
- PPO8
- POS4
- Medicare3
- EPO2
Source: Dmand AI Insurance Network Data
Sources for Dr. Luis E. Fayad's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Luis E. Fayad
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Luis E. Fayad's NPI number?
Dr. Luis E. Fayad's NPI number is 1205921095. It was assigned on October 4, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Luis E. Fayad?
Dr. Luis E. Fayad is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Luis E. Fayad practice?
Dr. Fayad practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Fayad's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Luis E. Fayad's medical license number?
Dr. Fayad holds Texas license J7482, one of the licenses on file in 5 states.
Which states has Dr. Luis E. Fayad been licensed in?
Dmand AI has state licenses on file for Dr. Fayad in Texas (1995 to 2026), Florida (since 2021), Oklahoma (2020 to 2021), Arizona (1999 to 2014) and Nevada (1997 to 2011).
Which hospitals is Dr. Luis E. Fayad affiliated with?
Dr. Fayad practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. Luis E. Fayad part of?
Dr. Fayad is linked to Physicians Referral Service.
Does Dr. Luis E. Fayad accept Medicare?
Yes. CMS data shows Dr. Fayad billed Medicare for 894 services in 2024, and Dr. Fayad accepts Medicare assignment.
Does Dr. Luis E. Fayad offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Fayad as offering telehealth services.
What is Dr. Luis E. Fayad's MIPS score?
Dr. Fayad's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Show 9 more questionsShow fewer questions
How many Medicare patients does Dr. Luis E. Fayad see?
CMS counts 280 Medicare patients who saw Dr. Fayad in 2024, with an average age of 72.
What services does Dr. Luis E. Fayad bill to Medicare?
In 2024, Dr. Fayad's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and hospital inpatient care (99232).
Where did Dr. Luis E. Fayad go to medical school?
Dr. Fayad graduated from Universidad Catolica de Santiago de Guayaquil in 1985.
What drugs does Dr. Luis E. Fayad prescribe most?
In 2024 Medicare Part D data, Dr. Fayad's most prescribed drugs by claims were Valacyclovir, Pantoprazole Sodium and Revlimid.
Has Dr. Luis E. Fayad received payments from drug or device companies?
CMS Open Payments shows $22,047 in general payments to Dr. Fayad from 18 companies from 2016 to 2025. The largest total came from Amgen Inc.
How long has Dr. Luis E. Fayad been practicing?
Dr. Fayad graduated from medical school in 1985, 41 years ago.
Does Dr. Luis E. Fayad do research?
Dmand AI links 219 publications to Dr. Fayad, published from 2004 to 2025. Dr. Fayad has worked on 5 clinical trials.
Who does Dr. Luis E. Fayad publish with?
Dr. Fayad's most frequent co-authors are Sattva S. Neelapu, MD (84 shared papers), Fredrick B. Hagemeister, MD (72 shared papers) and Jason R. Westin, MD (70 shared papers).
What insurance does Dr. Luis E. Fayad accept?
Dr. Fayad is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card